Table 1.

Evaluation criteria of therapeutic efficacy of solid tumor.

Terms	Definition
Target lesion evaluation
Complete remission, CR	Target lesion disappeared
Partial remission, PR	Reduction of axial length of lesion baseline >30%
Stable disease, SD	Reduction of axial length of lesion baseline <30% or increase of axial length of lesion baseline >20%
Progression disease, PD	Progression disease
No target lesion evaluation
CR	All non-target lesions disappeared and tumor markers were at normal levels
SD	One or more non-target lesions and/or tumor markers higher than normal levels
PD	One or more new lesions or/and non-target lesions were present